Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 08, 2008. The report serves as a notification of transactions involving a Person Discharging Managerial Responsibility (PDMR) in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding executive compensation and does not contain financial performance data.
Material Changes
The filing details a specific transaction for Dr. R G Greig:
- Event: Vesting of 2,351.92 Ordinary Share ADRs under the GlaxoSmithKline Deferred Investment Award.
- Date of Vesting: February 01, 2008.
- Payment Details: Dr. Greig is due to receive a payment equivalent to $46.74 per ADR on February 22, 2008.
- Notification Date: The Company was advised of this transaction on February 07, 2008.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the total payout amount for Dr. R G Greig based on the vesting of 2,351.92 ADRs at $46.74 per unit.
- Confirm the payment execution date of February 22, 2008.
- Review the GlaxoSmithKline Deferred Investment Award terms to understand the vesting conditions.